CASP3 and neoplasm: This anti-tumor activity was attributed to mechanisms involving cancer cell apoptosis, as indicated by increased expression of active caspase-3, and reduced proliferation, evidenced by the downregulation of Ki67 biomarkers (Figure 5C).